Revenue: N/A; Gross Profit: N/A;
Operating Income: -$204,387 in QQ2 2025, QoQ +12.18% improvement, YoY +13.45% improvement;
Net Income: -$241,953 in QQ2 2025, QoQ -5.61%, YoY -71.30%;
EPS: -$0.0032 in QQ2 2025, QoQ -3.23%, YoY -68.42%;
EBITDA: -$202,527;
Interest Expense: $39,425;
Stock-based compensation: $50,670;
Change in Working Capital: -$33,177;
Free Cash Flow: -$185,035;
Cash and cash equivalents: $1,182,352;
Short-term debt: $466,292;
Total current assets: $1,213,745;
Total assets: $1,758,551;
Total current liabilities: $516,132;
Total liabilities: $516,132;
Total stockholdersโ equity: $1,242,419;
Current ratio: 2.35; Debt ratio: 0.265; Debt-to-equity: 0.375; Price-to-book: 23.33; Price-to-earnings: negative; Net debt: -$716,060;
Note: Four-quarter data shows Q1 2025 EPS -$0.0031, Q2 2025 EPS -$0.0032, Q3 2024 EPS -$0.0034, Q4 2024 EPS $0.0083, illustrating a volatile earnings trajectory in this micro-cap exploration-stage issuer.